Abstract

Liver failure causes breakdown of the Blood CNS Barrier (BCB) leading to damages of the Central-Nervous-System (CNS), however the mechanisms whereby the liver influences BCB-integrity remain elusive. One possibility is that the liver secretes an as-yet to be identified molecule(s) that circulate in the serum to directly promote BCB-integrity. To study BCB-integrity, we developed light-sheet imaging for three-dimensional analysis. We show that liver- or muscle-specific knockout of Hfe2/Rgmc induces BCB-breakdown, leading to accumulation of toxic-blood-derived fibrinogen in the brain, lower cortical neuron numbers, and behavioral deficits in mice. Soluble HFE2 competes with its homologue RGMa for binding to Neogenin, thereby blocking RGMa-induced downregulation of PDGF-B and Claudin-5 in endothelial cells, triggering BCB-disruption. HFE2 administration in female mice with experimental autoimmune encephalomyelitis, a model for multiple sclerosis, prevented paralysis and immune cell infiltration by inhibiting RGMa-mediated BCB alteration. This study has implications for the pathogenesis and potential treatment of diseases associated with BCB-dysfunction.

Blood vessel integrity is critical to maintain brain health. Here, the authors show that both the liver and the muscles secrete HFE2, a protein that promotes blood vessel integrity in healthy animals and in an animal model for multiple sclerosis.

Details

Title
The liver and muscle secreted HFE2-protein maintains central nervous system blood vessel integrity
Author
Wang, Xue Fan 1 ; Vigouroux, Robin 2   VIAFID ORCID Logo  ; Syonov, Michal 2 ; Baglaenko, Yuriy 3 ; Nikolakopoulou, Angeliki M. 4 ; Ringuette, Dene 2 ; Rus, Horea 5   VIAFID ORCID Logo  ; DiStefano, Peter V. 6 ; Dufour, Suzie 3 ; Shabanzadeh, Alireza P. 3 ; Lee, Seunggi 2 ; Mueller, Bernhard K. 7 ; Charish, Jason 2 ; Harada, Hidekiyo 3   VIAFID ORCID Logo  ; Fish, Jason E. 6   VIAFID ORCID Logo  ; Wither, Joan 3 ; Wälchli, Thomas 8   VIAFID ORCID Logo  ; Cloutier, Jean-François 9   VIAFID ORCID Logo  ; Zlokovic, Berislav V. 4   VIAFID ORCID Logo  ; Carlen, Peter L. 10   VIAFID ORCID Logo  ; Monnier, Philippe P. 11   VIAFID ORCID Logo 

 University Health Network, Krembil Discovery Tower, Krembil Research Institute, Toronto, Canada (GRID:grid.231844.8) (ISNI:0000 0004 0474 0428); University of Toronto, Institute of Biomedical and Biomaterial Engineering, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 University Health Network, Krembil Discovery Tower, Krembil Research Institute, Toronto, Canada (GRID:grid.231844.8) (ISNI:0000 0004 0474 0428); University of Toronto, Department of Physiology, Faculty of Medicine, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 University Health Network, Krembil Discovery Tower, Krembil Research Institute, Toronto, Canada (GRID:grid.231844.8) (ISNI:0000 0004 0474 0428) 
 Keck School of Medicine of the University of Southern California, Department of Physiology and Neuroscience, The Zilkha Neurogenetic Institute, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853) 
 University of Maryland, School of Medicine, Department of Neurology, Baltimore, USA (GRID:grid.411024.2) (ISNI:0000 0001 2175 4264) 
 University Health Network, Toronto General Hospital Research Institute, Toronto, Canada (GRID:grid.231844.8) (ISNI:0000 0004 0474 0428) 
 BioNTech resano GmbH, Mainz, Germany (GRID:grid.17063.33) 
 University Health Network, Krembil Discovery Tower, Krembil Research Institute, Toronto, Canada (GRID:grid.231844.8) (ISNI:0000 0004 0474 0428); University and University Hospital Zurich, Group of CNS Angiogenesis and Neurovascular Link, and Physician-Scientist Program, Institute for Regenerative Medicine, Neuroscience Center Zurich, and Division of Neurosurgery, Zurich, Switzerland (GRID:grid.412004.3) (ISNI:0000 0004 0478 9977); University Hospital Zurich, Division of Neurosurgery, Zurich, Switzerland (GRID:grid.412004.3) (ISNI:0000 0004 0478 9977); University Health Network, Division of Neurosurgery, Department of Surgery, Toronto Western Hospital, Toronto, Canada (GRID:grid.231844.8) (ISNI:0000 0004 0474 0428) 
 The Neuro - Montreal Neurological Institute and Hospital, Montréal, Canada (GRID:grid.416102.0) (ISNI:0000 0004 0646 3639) 
10  University Health Network, Krembil Discovery Tower, Krembil Research Institute, Toronto, Canada (GRID:grid.231844.8) (ISNI:0000 0004 0474 0428); University of Toronto, Institute of Biomedical and Biomaterial Engineering, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); Keck School of Medicine of the University of Southern California, Department of Physiology and Neuroscience, The Zilkha Neurogenetic Institute, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853) 
11  University Health Network, Krembil Discovery Tower, Krembil Research Institute, Toronto, Canada (GRID:grid.231844.8) (ISNI:0000 0004 0474 0428); University of Toronto, Institute of Biomedical and Biomaterial Engineering, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); University of Toronto, Department of Ophthalmology and Vision Sciences, Faculty of Medicine, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
Pages
1037
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2921585976
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.